Crenza Pharmaceuticals

Hyderabad, India Founded: 2017 • Age: 9 yrs
Offers contract-based development and manufacturing of pharmaceutical injectables and ophthalmic drugs.

About Crenza Pharmaceuticals

Crenza Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2017. It offers contract-based development and manufacturing of pharmaceutical injectables and ophthalmic drugs. It operates on a B2B model. The company has 31 employees. Its Indian entity Crenza Pharmaceuticals Private Limited reported revenue of β‚Ή5.97 Cr. Crenza Pharmaceuticals offers products and services including Contract Manufacturing, Contract Packaging, Analytical Services, Stability Studies, and Formulation Development. Its focus areas include Pharmaceuticals, Drug Development and Injectables and Ophthalmics. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Crenza Pharmaceuticals Pvt. Ltd. is a contract research organization based in Hyderabad, India, specializing in the development and manufacturing of complex injectable and ophthalmic drugs. They provide services like formulation development, analytical studies, stability testing, and packaging through collaborative client relationships. Using RD expertise and advanced technologies, they deliver high-quality solutions at competitive prices for global markets, ensuring regulatory compliance and efficient commercialization.

  • Headquarters Hyderabad, India
  • Employees 31
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website crenzapharma.com
  • Legal Name Crenza Pharmaceuticals Private Limited
  • Date of Incorporation 22 May, 2017
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹5.97 Cr

    FY 2025 · +3% YoY

  • Net Profit
    ₹25.8 Lakh

    FY 2025 · 4% margin

  • EBITDA
    ₹1.14 Cr

    FY 2025 · 19% margin

  • Employee Count
    31

Products & Services of Crenza Pharmaceuticals

Crenza Pharmaceuticals offers a comprehensive portfolio of products and services, including Contract Manufacturing, Contract Packaging, Analytical Services, Stability Studies, and Formulation Development.

Contract Manufacturing
Manufacturing Services

Manufactures pharmaceutical injectables and ophthalmic drugs for clients.

Contract Packaging
Packaging Services

Provides packaging for pharmaceutical products to meet standards.

Analytical Services
Testing Services

Conducts testing for active ingredients and excipients in drugs.

Stability Studies
Research Services

Performs stability testing for pharmaceutical formulations.

Formulation Development
Development Services

Develops formulations for injectables and ophthalmic drugs.

Board of directors of Crenza Pharmaceuticals Private Limited (Crenza Pharmaceuticals)

Crenza Pharmaceuticals Private Limited is the primary company behind Crenza Pharmaceuticals. The board of Crenza Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Sandhya Pittala, appointed in 2017. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Sandhya Pittala
DIN 07812468
Whole-time director22 May 20179 yrs 5 moCrenza Pharmaceuticals Private Limited
Satyanarayana Pittala
DIN 08467067
Director30 May 20197 yrs 5 moCrenza Pharmaceuticals Private Limited

Financials of Crenza Pharmaceuticals

Figures of Crenza Pharmaceuticals Private Limited, the primary company behind Crenza Pharmaceuticals, for FY 2025. Revenue was ₹5.97 Cr (+3% year on year). Net profit was ₹25.8 Lakh (4% margin). EBITDA was ₹1.14 Cr (19% margin). Revenue has grown at a compounded annual rate of +12% over three years and +13% over five years.

  • ₹5.97 CrRevenue · FY 2025 · +3% YoY
  • ₹25.8 LakhNet profit · 4% margin
  • ₹1.14 CrEBITDA · 19% margin
  • ₹50,000Paid-up capital
  • 31Employees (provident fund records)
  • +12%Revenue CAGR, 3 years
  • +13%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Crenza Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Crenza Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Crenza Pharmaceuticals

Crenza Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Crenza Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Crenza Pharmaceuticals

Crenza Pharmaceuticals was founded in 2017.

Crenza Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Crenza Pharmaceuticals has 31 employees.

The primary company behind Crenza Pharmaceuticals, Crenza Pharmaceuticals Private Limited, reported revenue of β‚Ή5.97 Cr for FY 2025, up 3% year on year.

Crenza Pharmaceuticals Pvt. Ltd. is a contract research organization based in Hyderabad, India, specializing in the development and manufacturing of complex injectable and ophthalmic drugs. They provide services like formulation development, analytical studies, stability testing, and packaging through collaborative client relationships. Using RD expertise and advanced technologies, they deliver high-quality solutions at competitive prices for global markets, ensuring regulatory compliance and efficient commercialization.

Crenza Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Crenza Pharmaceuticals offers Contract Manufacturing, Contract Packaging, Analytical Services, Stability Studies, and Formulation Development.

Crenza Pharmaceuticals operates through Crenza Pharmaceuticals Private Limited.

The legal entities of Crenza Pharmaceuticals currently have 2 directors, including Sandhya Pittala, Satyanarayana Pittala.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available